CClinicalTrials.gg
CompletedNCT02345525Updated Dec 20, 2017

Constraint-Induced Movement Therapy in Chronic Stroke Patients

An interventional study of mCIMT and hCIMT in Stroke, sponsored by University Hospital of Ferrara. Completed at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-12-20.

Sponsored by University Hospital of Ferrara · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the feasibility of a Home-based Constraint-Induced Movement Therapy (hCIMT) compared to a Modified Constraint-Induced Movement Therapy (mCIMT) delivered in a outpatient setting on upper limb motor recovery in stroke survivors.

Read the detailed description

Home-based Constraint Induced Modified Therapy (hCIMT) consist of 2 hours intensive upper limb practice with shaping techniques + 2 hours ADLs supervised by a caregiver. Patients are supposed to wear a mitt on the unaffected hand for 4 hours daily.

Modified Constraint Induced Modified Therapy (mCIMT) consist of 2 hours intensive upper limb practice with shaping techniques supervised by an experienced physiotherapist + 2 hours ADLs at home (supervised by a caregiver) Patients are supposed to wear a mitt on the unaffected hand for 4 hours daily.

02

Conditions studied

  • Stroke

Browse trials for

03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 20 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University Hospital of Ferrara is the lead sponsor of 110 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age > 18 years and \< 80 years
  • diagnosis of first ischemic stroke
  • stroke onset > 6 months prior to study enrollment
  • upper extremity hemiparesis with impairment of hand and/or arm:
  • active wrist extension ≥20º
  • active metacarpophalangeal- and interphalangeal-joints extension ≥ 10°
  • muscle tone assessed by the Modified Ashworth Scale (MAS) ≤ 2
  • pain assessed by the Visual Analogue Scale (VAS) \<4

Exclusion criteria

Exclusion Criteria:

  • anyone who does not have adequate understanding of verbal or written information in Italian sufficient to complete any test
  • impaired cognitive functioning: score less than 24 on the Mini Mental Status Examination (MMSE)
  • contraindications to single-pulse transcranial magnetic stimulation (TMS)(TMS will be used to measure cortical excitability): presence of a history of epilepsy, frequent headaches or neck pain, implantable devices (ventriculoperitoneal shunts, pacemakers, intrathecal pumps, intracranial metal implants)
  • neurological or psychiatric pathology
  • severe cardio-pulmonary, renal, hepatic diseases
  • pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Active comparator
    mCIMT

    2 hours intensive upper limb practice with shaping techniques supervised by an experienced physiotherapist + 2 hours ADLs at home (supervised by a caregiver) Patients are supposed to wear a mitt on the unaffected hand for 4 hours daily.

    Behavioral: mCIMT

  • Experimental
    hCIMT

    2 hours intensive upper limb practice with shaping techniques + 2 hours ADLs supervised by a caregiver. Patients are supposed to wear a mitt on the unaffected hand for 4 hours daily.

    Behavioral: hCIMT

Interventions

  • BehavioralmCIMT

    This intervention is based on 3 main aspects: 1. intensive training of functional tasks with the affected arm (massed practice) 2. constraint of the un-affected hand through a mitt 3. shaping techniques designed to transfer gains to the real world activities The 2 hours massed practice will be performed in a outpatient clinic with a supervision of PT.

  • BehavioralhCIMT

    This intervention is based on 3 main aspects: 1. intensive training of functional tasks with the affected arm (massed practice) 2. constraint of the un-affected hand through a mitt 3. shaping techniques designed to transfer gains to the real world activities In this group, a comprehensive set of the material necessary to perform the training at home and a booklet containing an explanation of the exercises that can be done will be provided to subjects. In addition, 2 hospital visits will be scheduled to instruct subjects and caregivers on the training and to update activities (1 visit at the beginning + 1 visit after 1 week).

06

What researchers measure

Primary outcomes

  1. Changes from baseline in Fugl-Meyer Upper Extremity (FM-UE)

    Measure of upper extremity motor impairment. The upper extremity score ranges from 0-66.

    Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up

Secondary outcomes

  1. Wolf Motor Function Test (WMFT)

    Quantitative measure of upper extremity motor ability through timed and functional tasks.

    Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up

  2. Nine Hole Peg Test (NHPT

    Measures finger dexterity

    Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up

  3. Motor Activity Log (MAL)

    Assessment of the change in real-world arm use in activities of daily living. Subjects are asked to score the quality of movement as well as amount of use of the affected arm in a number of common daily activities.

    Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up

  4. Stroke Impact Scale 3.0 (SIS 3.0)

    Self-assessment questionnaire assesses health status following stroke

    Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up

  5. Motor cortex excitability (single pulse and paired pulse TMS)

    Single-Pulse TMS will be used to study cortical-spinal tract excitability in primary motor cortex (M1). Paired-pulse TMS Paired-Pulse TMS will be used to study intracortical excitability.

    Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up

  6. NIRS (Near Infrared Spectroscopy) NIRS measurements will be performed during 6 cycles of 15s hand reaching and grasping and 45s resting while sitting on a chair.

    For the NIRS it will use an 32-channel NIRS imaging equipment which consist of 16 pairs of emitting and detecting optical fibers attached to a custom-made head cap placed on primary motor cortex. NIRS measurements will be performed during 6 cycles of 15s hand reaching and grasping and 45s resting while sitting on a chair.

    Time frame: 1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up

07

Study locations

1 site
  • Ferrara University Hospital
    Ferrara, 44124, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 20, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02345525
Lead sponsor
University Hospital of Ferrara
Responsible party
Sponsor
First posted
Jan 26, 2015
Start date
Aug 2014
Primary completion
May 2017
Completion
Aug 2017
Last update
Dec 20, 2017

Study contacts

Sofia Straudi, MD
principal investigator · Ospedale San Giorgio

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion